Read more about antimalarial drugs for pregnant women and how MMV works to remedy this with the Malaria in Mothers and Babies (MiMBa) strategy.

MMV Open A suite of free-to-use tools for drug discovery to foster collaboration amongst researchers in malaria and other neglected diseases MMVFree

Open innovation is at the core of MMV’s discovery activities. In development, we work closely with global and local partners to co-create drug development strategies and deliver a portfolio of …

Provide networking opportunities with different stakeholders (both North–South as well as South–South), such as academic institutions, pharmaceutical industries, trial sites, public …

It’s working. As of 2024, MMV-supported products have effectively treated an estimated 711 million people and saved around 17.4 million lives (if there had been no other treatment …

MMV is seeking proposals with the goal to discover and develop new innovative technologies for the treatment or chemoprevention of malaria.

MMV is a Swiss-based not-for-profit organization working to deliver a portfolio of accessible medicines with the power to treat, prevent and eliminate malaria.

Jun 24, 2024 · Read an in-depth overview of MMV's activities and our financial statements for 2023.

Summary of MMV's Target Candidate Profiles (TCPs): TCP-1: Molecules that clear asexual blood-stage parasitemia TCP-2: (profile retired, see full article for more information)

Oct 30, 2024 · A recent market study conducted by MMV on the deployment of multiple first-line treatments (MFT) to address antimalarial drug resistance has been selected by Tropical …